Literature DB >> 24155241

Dendrimers as high relaxivity MR contrast agents.

Michelle R Longmire1, Mikako Ogawa, Peter L Choyke, Hisataka Kobayashi.   

Abstract

Dendrimers are versatile macromolecules with tremendous potential as magnetic resonance imaging (MRI) contrast agents. Dendrimer-based agents provide distinct advantages over low-molecular-weight gadolinium chelates, including enhanced r1 relaxivity due to slow rotational dynamics, tunable pharmacokinetics that can be adapted for blood pool, liver, kidney, and lymphatic imaging, the ability to be a drug carrier, and flexibility for labeling due to their inherent multivalency. Clinical applications are increasingly being developed, particularly in lymphatic imaging. Herein we present a broad overview of dendrimer-based MRI contrast agents with attention to the unique chemistry and physical properties as well as emerging clinical applications.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24155241      PMCID: PMC6330103          DOI: 10.1002/wnan.1250

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  7 in total

Review 1.  Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.

Authors:  Sue Hyun Lee; Jung Bok Lee; Min Soo Bae; Daniel A Balikov; Amy Hwang; Timothy C Boire; Il Keun Kwon; Hak-Joon Sung; Jae Won Yang
Journal:  Adv Healthc Mater       Date:  2015-06-29       Impact factor: 9.933

2.  Opportunities in Interventional and Diagnostic Imaging by Using High-Performance Low-Field-Strength MRI.

Authors:  Adrienne E Campbell-Washburn; Rajiv Ramasawmy; Matthew C Restivo; Ipshita Bhattacharya; Burcu Basar; Daniel A Herzka; Michael S Hansen; Toby Rogers; W Patricia Bandettini; Delaney R McGuirt; Christine Mancini; David Grodzki; Rainer Schneider; Waqas Majeed; Himanshu Bhat; Hui Xue; Joel Moss; Ashkan A Malayeri; Elizabeth C Jones; Alan P Koretsky; Peter Kellman; Marcus Y Chen; Robert J Lederman; Robert S Balaban
Journal:  Radiology       Date:  2019-10-01       Impact factor: 11.105

3.  A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.

Authors:  Zhen Ye; Zhuxian Zhou; Nadia Ayat; Xueming Wu; Erlei Jin; Xiaoyue Shi; Zheng-Rong Lu
Journal:  Contrast Media Mol Imaging       Date:  2015-07-27       Impact factor: 3.161

4.  Dendrimer-Based Responsive MRI Contrast Agents (G1-G4) for Biosensor Imaging of Redundant Deviation in Shifts (BIRDS).

Authors:  Yuegao Huang; Daniel Coman; Fahmeed Hyder; Meser M Ali
Journal:  Bioconjug Chem       Date:  2015-11-05       Impact factor: 4.774

Review 5.  A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.

Authors:  Gulinigaer Anwaier; Cong Chen; Yini Cao; Rong Qi
Journal:  Int J Nanomedicine       Date:  2017-10-19

Review 6.  Applications and Limitations of Dendrimers in Biomedicine.

Authors:  Adriana Aurelia Chis; Carmen Dobrea; Claudiu Morgovan; Anca Maria Arseniu; Luca Liviu Rus; Anca Butuca; Anca Maria Juncan; Maria Totan; Andreea Loredana Vonica-Tincu; Gabriela Cormos; Andrei Catalin Muntean; Maria Lucia Muresan; Felicia Gabriela Gligor; Adina Frum
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

Review 7.  Cytotoxicity of Dendrimers.

Authors:  Anna Janaszewska; Joanna Lazniewska; Przemysław Trzepiński; Monika Marcinkowska; Barbara Klajnert-Maculewicz
Journal:  Biomolecules       Date:  2019-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.